ASG-5ME is a drug-antibody coupling targeting SLC44A4 that shows anti-tumor activity in xenograft models and may be used to study pancreatic and gastric cancer.
Purity:
98.10%
Target:
Sodium Channel
* VAT and and shipping costs not included. Errors and price changes excepted
